Dupont Capital Management Corp Sangamo Therapeutics, Inc Transaction History

Dupont Capital Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$10.88 - $17.05 $260,108 - $407,614	-23,907 Closed	0 $0
Q4 2020 Jan 28, 2021	SELL	$9.23 - $18.18 $57,669 - $113,588	-6,248 Reduced 20.72%	23,907 $373,000
Q3 2020 Oct 29, 2020	SELL	$9.38 - $12.48 $18,947 - $25,209	-2,020 Reduced 6.28%	30,155 $285,000
Q2 2020 Jul 24, 2020	SELL	$6.21 - $11.83 $88,703 - $168,979	-14,284 Reduced 30.75%	32,175 $288,000
Q4 2019 Jan 27, 2020	BUY	$8.03 - $11.7 $117,358 - $170,995	14,615 Added 45.9%	46,459 $389,000
Q3 2019 Oct 28, 2019	BUY	$9.05 - $12.22 $288,188 - $389,133	31,844 New	31,844 $288,000
Q2 2018 Jul 30, 2018	SELL	$13.9 - $19.8 $188,803 - $268,943	-13,583 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$16.7 - $26.35 $226,836 - $357,912	13,583 New	13,583 $258,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $191M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.